Cyber Swan Sale

50% Off Elite

Days

Hours

Mins

Sec

Get our most powerful screeners, new charting tools, and the fastest ad-free experience at our best price ever. One last chance.

IHE

iShares U.S. Pharmaceuticals ETF

Dec 01 • 04:00PM ET

84.18

-1.18 -1.38 %

Financial • Exchange Traded Fund • USA • NYSE

Held by: AESR

Category	US Equities - Industry Sector	Asset Type	Equities (Stocks)	Tags	U.S.	Return% 1Y	26.19%	Total Holdings	48	Perf Week	1.57%
Sponsor	Blackrock (iShares)	ETF Type		Tags	equity	Return% 3Y	13.45%	AUM	802.14M	Perf Month	11.85%
Fund Family		Bond Type		Tags	pharmaceutical	Return% 5Y	10.02%	NAV/sh		Perf Quarter	17.97%
Index	Dow Jones US Sel Pharmaceuticals Indx	Average Maturity		Tags	-	Return% 10Y		52W High	86.17 -2.31%	Perf Half Y	28.72%
Index Weighting		Commodity Type		Tags	-	Return% SI		52W Low	58.97 42.74%	Perf YTD	28.09%
Active/Passive		Quant Type		Tags	-	Flows% 1M	16.51%	Volatility	1.27% 1.53%	Perf Year	22.35%
Dividend TTM	1.12 (1.33%)	ESG Type		Tags	-	Flows% 3M	15.37%	ATR (14)	1.20	Perf 3Y	37.81%
Dividend Ex-Date	Sep 16, 2025	Dividend Type		Sector/Theme		Flows% YTD	4.03%	RSI (14)	70.63	Perf 5Y	47.67%
Dividend Gr. 3/5Y	4.71% 8.83%	Structure Type		Region		Flows% 1Y		Beta	0.52	Perf 10Y	59.01%
Expense	0.38%	Growth/Value		SMA20	4.32%	Flows% 3Y		Rel Volume	1.17	Prev Close	85.36
Inverse/Leveraged		Market Cap		SMA50	9.99%	Flows% 5Y		Avg Volume	65.21K	Price	84.18
IPO	May 05, 2006	Option/Short	Yes / Yes	SMA200	20.44%	Trades		Volume	75,083	Change	-1.38%

Nov-24-25 07:00AM	Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest in (Zacks)
Nov-14-25 07:59AM	Pharma ETFs in Spotlight Following Robust Q3 Earnings Results (Zacks)
Nov-10-25 07:47AM	Does Trump's MFN Policy Put Pharma ETFs in the Crosshairs? (Zacks)
Nov-05-25 09:00AM	Pharma ETF (IHE) Hit a 52-Week High (Zacks)
Oct-16-25 08:52AM	ETFs to Watch Post JNJ's Q3 Earnings Surprise & Bullish Outlook (Zacks)
03:26PM	Loading…
Oct-09-25 03:26PM	A Major Eli Lilly Shareholder Has Sold Stock Nearly Every Day in October. Here's Who It Is. (Barrons.com)
Oct-06-25 06:57AM	4 Reasons to Buy Pharma ETFs Now for a Healthy Portfolio (Zacks)
Sep-26-25 09:24AM	Trump Slams 100% Tariff on Imported Drugs: Pharma ETFs Take a Hit (Zacks)
Sep-02-25 06:20AM	Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? (Zacks)
Aug-26-25 09:25AM	Lilly obesity-pill trial results find a warmer reception on Wall Street this time around (MarketWatch)
Aug-08-25 11:00AM	ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data (Zacks)
Jul-22-25 06:20AM	Should You Invest in the VanEck Pharmaceutical ETF (PPH)? (Zacks)
Jul-17-25 11:00AM	ETFs to Gain on JNJ's Solid Q1 Earnings & Upbeat Outlook (Zacks)
Jul-01-25 06:20AM	Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? (Zacks)
Jun-18-25 06:20AM	Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? (Zacks)
06:20AM	Loading…
May-21-25 06:20AM	Should You Invest in the VanEck Pharmaceutical ETF (PPH)? (Zacks)
May-12-25 12:52PM	ETFs on the Move Post U.S.-China Trade Deal (Zacks)
10:30AM	Pharma ETFs in Focus on Trump's Drug Price Overhaul (Zacks)
May-09-25 06:20AM	Is Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now? (Zacks)
May-08-25 11:50AM	A Look at Pharma ETFs After Strong Q1 Earnings (Zacks)
May-02-25 03:25AM	Aim To Keep Risk Modest And Quality High (Seeking Alpha)
Apr-30-25 04:35AM	3 Ways To Avoid The Eye Of The Equity Market Storm (Seeking Alpha)
04:33AM	Is Healthcare Losing the Status of Safe Haven? ETFs in Focus (Zacks)
Apr-28-25 06:20AM	Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? (Zacks)
Apr-23-25 05:45AM	Rewiring Global Trade For Resilience And Growth (Seeking Alpha)
Apr-21-25 08:30AM	Healthcare ETFs Tug of War: Insurers Tumble, Pharma Surges (Zacks)
Apr-18-25 01:40PM	Institutional, Retail Investors Shed $27B In U.S. Stocks In Early April Sell-Off (Seeking Alpha)
Apr-17-25 06:20AM	Should You Invest in the Invesco Pharmaceuticals ETF (PJP)? (Zacks)
Apr-16-25 10:00AM	ETFs in Focus Post JNJ's Q1 Earnings Beat, Dividend Hike (Zacks)
Apr-14-25 09:15AM	PPH: Will Overcome Tariffs, But Competitor Funds Look Stronger (Seeking Alpha)
08:30AM	Loading…
Apr-04-25 08:30AM	How Will New Tariffs Impact Your Investment Portfolio In 2025? (Seeking Alpha) -5.27%
Apr-02-25 07:00AM	The Great Transformation: Riding The Wave Of Change (Seeking Alpha)
Apr-01-25 05:40AM	U.S. Consumers To Be Hit Hardest By Pharmaceutical Tariffs (Seeking Alpha)
Mar-29-25 12:50AM	Trade Turbulence And The Tariff-ic Mess For Investors (Seeking Alpha)
Mar-28-25 06:05AM	Volatility Brings Changes To Market Leadership (Seeking Alpha)
Mar-20-25 04:32PM	How ESG Policies Can Keep The Healthcare Sector Fighting Fit (SeekingAlpha)
06:20AM	Should You Invest in the VanEck Pharmaceutical ETF (PPH)? (Zacks)
Dec-21-23 01:45PM	BlackRock Announces Product Updates to 10 iShares ETFs (Business Wire)
Sep-20-22 03:13PM	Best Pharmaceutical ETFs for Q4 2022 (Investopedia)
Feb-11-22 11:21AM	Pfizer Positioned for Future Upside (Investopedia)
Apr-09-20 01:20PM	Dividend Investors Should Buy Johnson & Johnson Stock On Pullbacks (InvestorPlace)
Feb-07-20 11:05AM	Pharma ETFs Gain on Healthy Q4 Earnings (Zacks)
Jan-16-20 01:00PM	4 Sector ETFs Sizzling With Solid Buybacks (Zacks)
Jan-15-20 01:32PM	4 Sector ETFs Sizzling With Solid Buybacks (Zacks)
Dec-20-19 08:10AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Nov-06-19 11:00AM	Pharma ETFs Set to Benefit Post Strong Q3 Earnings (Zacks)
Oct-16-19 10:05AM	JNJ Beats, Ups View: Healthcare ETFs to Buy (Zacks)
Oct-15-19 06:43PM	Johnson & Johnson, UnitedHealth Give Healthcare ETFs a Much Needed Bolster Shot (ETF Trends)
Sep-11-19 04:43PM	Potential Peanut Allergy Treatment Gives Pharma Company A Boost (ETF Trends)
Aug-27-19 04:11PM	Stock market news: August 27, 2019 (Yahoo Finance)
Aug-22-19 11:12AM	8 ETFs to Capture Opportunities in Healthcare Sector (ETF Trends)
Aug-07-19 10:59AM	Pharma Q2 Earnings Growth Highest: Time to Buy ETFs? (Zacks)
Jul-17-19 10:50AM	Healthcare ETFs in Focus on JNJ's Q2 Earnings Beat (Zacks)
Jul-14-19 11:00AM	4 Hot Pharmaceutical ETFs (ETF Trends)
Jun-26-19 11:00AM	AbbVie to Buy Allergan: Prescribed ETFs (Zacks)
Jun-25-19 06:01PM	AbbVie, Allergan Deal Puts Spotlight on Pharmaceutical ETFs (ETF Trends)
May-14-19 05:40PM	Legal Troubles Beset Pharmaceutical Sector ETFs (ETF Trends)
May-09-19 10:05AM	Pharma ETFs Down Despite Solid Q1 Results (Zacks)
Apr-18-19 05:00PM	Pharmaceutical ETFs Catch Healthcare Contagion (ETF Trends)
Apr-17-19 10:35AM	JNJ Beats, Ups Sales Growth View: Healthcare ETFs in Focus (Zacks)
Apr-09-19 02:14PM	4 ETFs to Consider with Big Pharma on the Senates Hot Seat (ETF Trends)
Mar-13-19 06:30AM	Look Out for Big Pharma Credit Downgrades This Year (Barrons.com)
Mar-01-19 08:00AM	Why These Pharma ETFs Rallied on Thursday (Zacks)
Feb-21-19 10:08AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Feb-14-19 01:43PM	Is Johnson & Johnson CEO Alex Gorsky Earning His Pay? (InvestorPlace)
Feb-07-19 11:15AM	A Look at Pharma ETFs Post Q4 Results (Zacks)
Jan-29-19 09:08AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Jan-23-19 10:59AM	JNJ Beats, Offers Bleak Outlook: Health Care ETFs in Focus (Zacks)
Jan-07-19 09:27AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Jan-04-19 10:01AM	Bristol-Myers to Acquire Celgene: Healthcare ETFs in Focus (Zacks)
Dec-27-18 09:35AM	AbbVie Stock: 3 Pros and 3 Cons to Consider Before Investing in ABBV (InvestorPlace)
Dec-14-18 03:32PM	Healthcare ETFs Looked Pale on Reports J&J Knew About Asbestos in Baby Powder (ETF Trends)
09:28AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Oct-22-18 03:30PM	ETF Plays for a Divided Midterm Elections (ETF Trends)
Oct-09-18 11:39AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Sep-06-18 04:56PM	Pharmaceutical ETFs Could Maintain Their Momentum (ETF Trends)
Aug-28-18 06:40PM	3 ETFs for Johnson & Johnson's Healthy Breakout (Investopedia)
Jul-03-18 03:19PM	July Could Be a Volatile Month for Pharma ETFs (ETF Trends)
Jun-08-18 04:01PM	Play the Best Sector of Summer With These ETFs & Stocks (Zacks)
May-11-18 03:42PM	Trump lets drug companies off the hook (Yahoo Finance)
Apr-24-18 06:41AM	Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? (Zacks)
Jan-26-18 10:32AM	Pfizer: Analysts Ratings and Recommendations for 4Q17 (Market Realist)
Jan-18-18 02:28PM	Mercks & Co.s Valuation in January 2018 (Market Realist)
Jan-11-18 09:02AM	How Mylans Rest of the World Segment Performed in 3Q17 (Market Realist)
Jan-10-18 08:16AM	3 Charts That Suggest Pharma Stocks Are a Buy in 2018 (Investopedia)
Nov-13-17 07:00AM	Mixed Prognosis for Healthcare Stocks (InvestorPlace)
Oct-30-17 12:25PM	Top 3 Pharmaceutical ETFs of 2017 (Investopedia)
Sep-26-17 01:55PM	The dollar will strengthen as the US is the only game in town: NYSE trader (Yahoo Finance Video)
01:55PM	Any stock weakness is end-of-quarter related: NYSE trader (Yahoo Finance Video)
Sep-22-17 01:14PM	Dow 23,000 hinges on earnings season: NYSE trader (Yahoo Finance Video)
09:40AM	Yahoo Finance Live: Midday Movers - Sep 22nd, 2017 (Yahoo Finance Video)
Sep-11-17 09:06AM	Behind the Latest Developments for Mercks Keytruda (Market Realist)
Sep-08-17 09:07AM	This Could Drive Jazz Pharmaceuticals Revenue Growth (Market Realist)
Sep-01-17 09:06AM	Pfizers Sterile Injection Pharmaceuticals in 2Q17 and 1H17 (Market Realist)
Aug-31-17 03:02PM	Eli Lillys Valuations after Its 2Q17 Earnings (Market Realist)
01:39PM	Why $475,000 isn't actually that expensive for Novartis's new drug (Yahoo Finance)
01:05PM	Why a $475,000 drug price tag isn't expensive (Yahoo Finance Video)
Aug-30-17 02:27PM	Trump can lower U.S. drug prices by fixing NAFTA (Yahoo Finance)
Aug-29-17 07:40AM	Johnson & Johnsons 2Q17 Performance, by Segment (Market Realist)
Aug-28-17 10:36AM	How Mercks Zepatier and Isentress Are Positioned after 2Q17 (Market Realist)

iShares U.S. Pharmaceuticals ETF seeks to track the investment results of the Dow Jones U.S. Select Pharmaceuticals Index. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index. The underlying index measures the performance of the pharmaceuticals sector of the U.S. equity market. The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund is non-diversified.

open in yahoo | open in marketwatch | open in google

Cyber Swan Sale

50% Off Elite

IHE

iShares U.S. Pharmaceuticals ETF

Upgrade your FINVIZ experience